Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Obesity

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booij, J; de Bruin, K; Eggels, L; la Fleur, SE; van de Giessen, E; van den Brink, W1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Obesity

ArticleYear
High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity.
    International journal of obesity (2005), 2013, Volume: 37, Issue:5

    Topics: Animals; Benzamides; Biological Availability; Contrast Media; Corpus Striatum; Diet; Diet, High-Fat; Dietary Carbohydrates; Dietary Fats; Dietary Sucrose; Dopamine Antagonists; Energy Intake; Feeding Behavior; Male; Obesity; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3

2013